Spero Therapeutics

Spero Therapeutics

Spero Therapeutics

Developing novel therapeutics for drug-resistant bacterial infections
Founded
2013
Raised
$84.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$51,700,000
Venture capital (Series C) - 2017
RA Capital Management Rock Springs Capital GV
$30,000,000
Venture capital (Series B) - 2016
Atlas Venture SR One Partners Innovation Fund +3
Team Size
2
Employees
PE HUB

VC-backed Spero Therapeutics sets IPO pricing terms

Stock markets Funding
PE HUB

VC-backed Spero Therapeutics files for IPO

Stock markets Health Funding
$51,700,000 Venture capital (Series C)
Spero Therapeutics

Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing

Xconomy

Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics

Funding Health
Xconomy

Spero Rolls up More Antibiotics With Vertex Deal

Health
Xconomy

Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs

Health Funding
$30,000,000 Venture capital (Series B)
FinSMEs

Spero Therapeutics Raised $30M in Series B Funding

Health Funding